Live cell imaging microscopes market to reach $2.5 billion by 2030 at 7.9% CAGR, driven by growing demand for cell-based research.
Read More
Live attenuated vaccines market to reach $41.11 billion by 2030 at 9.6% CAGR, driven by increasing prevalence of infectious diseases.
Read More
The global liraglutide market to reach $10.23 billion by 2030 at 8.3% CAGR, driven by increasing diabetic population.
Read More
Lipid regulators market to reach $10.38 billion by 2030 at 5.9% CAGR, driven by increasing prevalence of cardiovascular diseases.
Read More
Lifestyle-related disease supplements market to reach $91.73 billion by 2030 at 9.5% CAGR, driven by rising awareness of health and wellness.
Read More
Lichen nitidus treatment market to reach $2.91 billion by 2030 at 7.4% CAGR, driven by significant growth in chemical exposure and rising prevalence of skin infections.
Read More
Levofloxacin market to reach $2.42 billion by 2030 at 5.9% CAGR, driven by rising number of bacterial infections and increasing healthcare expenditure.
Read More
Leuprorelin drugs market to reach $3.95 billion by 2030 at 6.5% CAGR, driven by increasing prevalence of prostate cancer and rising demand for ivf treatments.
Read More
Leuprolide acetate market to reach $3.71 billion by 2030 at 6.4% CAGR, driven by increasing prevalence of prostate cancer.
Read More
Leukotriene modifiers market to reach $30.63 billion by 2030 at 5.3% CAGR, driven by increasing incidence of asthma and allergic conditions.
Read More